Effectiveness of an intervention to improve quality care in reducing cardiovascular risk in hypertense patients;Efectividad de una intervención de mejora de calidad en la reducción del riesgo coronario y del riesgo de mortalidad cardiovascular en patientes hipertensos

Atencion Primaria

Volumn 37, Issue 9, 2006, Pages 498-503

  Gómez Marcos, Manuel A ^a,d   Ortiz, Luis García ^b   González Elena, Luis Javier ^b   Rodríguez, Angel Sánchez ^c  

^a Unidad Docente Medicina Familiar y Comunitaria   (Spain)

^b Biomedical Research Institute of Salamanca IBSAL   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d NONE   (Spain)

Author keywords

Cardiovascular disease; Coronary disease; Hypertension; Quality improvement

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEEDBACK SYSTEM; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL STAFF; MORTALITY; NURSING STAFF; PRACTICE GUIDELINE; URBAN AREA;

EID: 33746376972     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13089094     Document Type: Article

References (31)

1. Villar Álvarez F, Maiques Galán A, Brotons Cuixart C, et al. Grupos de expertos del PAPPS. Actividades preventivas cardiovasculares en atención primaria. Aten Primaria. 2003;32 Supl 2:27-41.
2. Anderson KM, Wilson PWF, Odell PM, et al. Un update coronary risk profile, A stament for health professionals. Circulation. 1991;83:3S6-62.
3. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction: American Heart Association. Circulation. 1998;97:1876-87.
4. Grundy S, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481-92.
5. Wilson P, D'Agostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
6. Marrugat J, Solanas P, D'Agostino R, et al. Estimación del riesgoi coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.
7. Brotons C, Mejoremos la predicción del riesgo coronario en España. Rev Esp Cardiol. 2003;56:225-7.
8. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 2003;24:987-1003.
9. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNV 7). Hypertension. 2003;42:1206-52.
10. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (AVHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-92.
11. Guidelines committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
12. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardio Prev Rev. 2003;10 Suppl 1:1-78.
13. García Ortiz L, Santos Rodríguez I, Sánchez Fernández PL, et al. Efectividad de una intervención de mejora de calidad en la reducción del riesgo cardiovascular en pacientes hipertensos. Rev Esp Cardiol. 2004;57:664-51.
14. Plaza Pérez I, Villar Álvarez F, Mata López P, et al. Control de la colesterolemia en España, 2000. Un instrumento para la prevención cardiovascular. Rev Esp Cardiol. 2002;53:815-37.
15. Executive summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): JAMA. 2001;285:2486-97.
16. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2004;27 Suppl 1:815-35.
17. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults (North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). NHLBI, Obesity Guidelines-Practical Guide; 2000.
18. Camacho Rosales J. Estadística con SPSS para Windows V.11. Madrid: RAMA; 2002.
19. Maiques A, Morales M, Franch M, et al. Cálculo del riesgo coronario de los pacientes incluidos en el Programa de Actividades Preventivas y de Promoción de la Salud. Aten Primaria. 1995;15:30-5.
20. Armero Garrigós E, Viribay Lorite F, Cabal García A, et al. Estimación del riesgo coronario en la población de 35-60 años adscrita a un centro de salud. Aten Primaria. 2003;32:577-82.
21. Jones AF, Walker J, Jewkes C, et al. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart. 2001;85:37-43.
22. Ferré Larrosa F, Fernández Herráez F, Pereñíguez JE, et al. Variación bienal del riesgo cardiovascular en los pacientes atendidos en los servicios de atención primaria: hipertensión, diabetes y dislipemias. Aten Primaria. 2001;27:542-6.
23. Martell Claros N, García Ruiz F, Rodríguez Domingo A, et al. Riesgo cardiovascular absoluto en hipertensos y su evolución con el tratamiento antihipertensivo. Hipertensión. 2001;18:72-7.
24. Villaseca J, Buxeda C, Cámara C, et al. ¿iTienen riesgo coronario los pacientes que tratamos con fármacos hipolipemiantes? Aten Primaria. 1997;20:49-53.
25. Bonné MV, González O, Charones E, et al. Riesgo coronario y prescripción en pacientes con hipercolesterolemia en atención primaria. Aten Primaria. 2000;25:209-13.
26. Barrios Alonso V, Campuzano Ruiz R, Peña Pérez G, et al. Estratificación del riesgo cardiovascular en hipertensión en Atención Primaria e impacto sobre el tratamiento antihipertensivo. Estudio DIORISC. Hipertensión. 2002;19:114-20.
27. Thomson O'Brien MA, Oxman AD, Davis DA, et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;(2):CD000259.
28. Review. Update in: Cochrane Database Syst Rev. 2003;(3): CD000259.
29. Thomson O'Brien MA, Oxman AD, Davis DA, et al. Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;(2):CD000260.
30. Freemantle N, Harvey EL, Wolf F, et al. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;(2):CD000172.
31. Oxman A, Thomson M, Davis D, et al. No magic bullets: systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J. 1995;153:1423-31.